Eastman Chemical (NYSE:EMN - Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 4,000,000 shares, an increase of 25.0% from the April 30th total of 3,200,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the short-interest ratio is currently 2.8 days. Currently, 3.5% of the company's shares are short sold.
Analysts Set New Price Targets
A number of brokerages have weighed in on EMN. Wall Street Zen downgraded Eastman Chemical from a "buy" rating to a "hold" rating in a report on Monday, April 28th. UBS Group decreased their target price on Eastman Chemical from $111.00 to $107.00 and set a "buy" rating for the company in a research note on Wednesday, May 28th. Barclays dropped their price target on Eastman Chemical from $108.00 to $85.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 29th. KeyCorp reduced their price objective on shares of Eastman Chemical from $120.00 to $106.00 and set an "overweight" rating for the company in a research report on Monday, April 28th. Finally, Wells Fargo & Company dropped their target price on shares of Eastman Chemical from $125.00 to $90.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 9th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $98.54.
Check Out Our Latest Stock Analysis on Eastman Chemical
Eastman Chemical Stock Up 0.7%
EMN stock traded up $0.54 during mid-day trading on Friday, reaching $78.88. 1,941,857 shares of the company traded hands, compared to its average volume of 1,163,080. The company has a quick ratio of 0.78, a current ratio of 1.51 and a debt-to-equity ratio of 0.78. The firm's 50 day moving average price is $78.86 and its 200 day moving average price is $89.77. The stock has a market cap of $9.11 billion, a price-to-earnings ratio of 10.27, a P/E/G ratio of 1.22 and a beta of 1.25. Eastman Chemical has a fifty-two week low of $70.90 and a fifty-two week high of $114.50.
Eastman Chemical (NYSE:EMN - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.02. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%. The business had revenue of $2.29 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the business earned $1.61 EPS. The business's revenue was down .9% on a year-over-year basis. As a group, equities research analysts predict that Eastman Chemical will post 8.55 EPS for the current fiscal year.
Eastman Chemical Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 8th. Shareholders of record on Friday, June 13th will be given a dividend of $0.83 per share. The ex-dividend date is Friday, June 13th. This represents a $3.32 annualized dividend and a dividend yield of 4.21%. Eastman Chemical's dividend payout ratio is currently 42.24%.
Institutional Trading of Eastman Chemical
Hedge funds have recently bought and sold shares of the business. Strs Ohio purchased a new position in shares of Eastman Chemical in the 1st quarter worth about $1,918,000. Ellsworth Advisors LLC purchased a new stake in Eastman Chemical during the first quarter valued at about $4,588,000. Belpointe Asset Management LLC grew its stake in Eastman Chemical by 20.3% in the 1st quarter. Belpointe Asset Management LLC now owns 5,111 shares of the basic materials company's stock valued at $450,000 after buying an additional 862 shares in the last quarter. Focus Partners Wealth grew its position in shares of Eastman Chemical by 28.4% in the first quarter. Focus Partners Wealth now owns 6,403 shares of the basic materials company's stock valued at $564,000 after purchasing an additional 1,415 shares in the last quarter. Finally, Bayforest Capital Ltd lifted its holdings in Eastman Chemical by 1,282.4% during the 1st quarter. Bayforest Capital Ltd now owns 4,700 shares of the basic materials company's stock worth $414,000 after purchasing an additional 4,360 shares in the last quarter. 83.65% of the stock is currently owned by institutional investors.
About Eastman Chemical
(
Get Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Read More
Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.